![](/img/cover-not-exists.png)
Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study
Petrioli, R, Pascucci, A, Conca, R, Chiriacò, G, Francini, E, Bargagli, G, Fiaschi, A I, Manganelli, A, De Rubertis, G, Barbanti, GVolume:
104
Year:
2011
Language:
english
Pages:
7
DOI:
10.1038/bjc.2011.5
File:
PDF, 322 KB
english, 2011